SCHEMBL4354094

SCHEMBL4354094

CCNc1cc(C)cc(COc2c(Br)cc(C(=O)NCC(=O)O)cc2Br)c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
THRB P10828 7/20 0.50
THRA P10827 6/20 0.50
SMN1; SMN2 Q16637 4/20 0.42
RAB9A P51151 2/20 0.40
MAPT P10636 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
NPC1 O15118 1/20 0.39
PAX8 Q06710 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
LMNA P02545 4/20 0.37
HPGD P15428 2/20 0.37
PDE5A O76074 1/20 0.36
EGLN1 Q9GZT9 1/20 0.36
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4932752 0.92 THRB (0.41) THRBTHRASMN1; SMN2RAB9AMAPT
SCHEMBL4354050 0.89 THRB (0.50) THRBTHRASMN1; SMN2RAB9AMAPT
SCHEMBL4358827 0.89 THRA (0.41) THRBTHRASMN1; SMN2RAB9AMAPT
SCHEMBL4927726 0.89 SMN1; SMN2 (0.43) THRBTHRASMN1; SMN2RAB9AMAPT
SCHEMBL4927337 0.88 THRB (0.49) THRBTHRASMN1; SMN2RAB9AMAPT
SCHEMBL4932425 0.88 LMNA (0.42) THRBTHRASMN1; SMN2RAB9AMAPT
SCHEMBL5118202 0.87 ALDH1A1 (0.41) THRBTHRASMN1; SMN2RAB9AMAPT
SCHEMBL4351934 0.87 THRA (0.42) THRBTHRASMN1; SMN2RAB9AMAPT
SCHEMBL4354703 0.87 THRA (0.42) THRBTHRASMN1; SMN2RAB9AMEN1
SCHEMBL4934084 0.87 THRA (0.39) THRBTHRASMN1; SMN2RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080835-A1 THYROMIMETRIC COMPOUNDS IN TREATMENT OF DISEASE RELATED TO SONIC HEDGEHOG SIGNALLING KARO BIO AB (SE) 2009-07-02 WO claimed
WO-2009080835-A1 THYROMIMETRIC COMPOUNDS IN TREATMENT OF DISEASE RELATED TO SONIC HEDGEHOG SIGNALLING KARO BIO AB (SE) 2009-07-02 WO disclosed
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA THRB 4/4885THRA 3/4885SMN1; SMN2 4282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.